Proposals for the GlaxoSmithKline Africa Open Lab are now invited. The GlaxoSmithKline Africa Open Lab 2024 Call for Proposals (up to 100,000 pounds) is a funding opportunity designed to support innovative research projects in Africa.

GlaxoSmithKline Africa Open Lab 2024 Call for Proposals
GlaxoSmithKline Africa Open Lab 2024 Call for Proposals

Application Deadline: January 29, 2024

The program is open to researchers and organizations in Sub-Saharan Africa who are working on projects related to drug discovery, neglected tropical diseases, and other areas of global health. With a deadline of January 29, 2024, this Call for Proposals is an excellent opportunity for African researchers to secure funding and advance their work.

GlaxoSmithKline Africa Open Lab 2024 Call for Proposals (up to 100,000 pounds)

With up to 100,000 pounds available per grant, they are seeking research proposals with the goal of supporting high-quality infectious disease research that might have a major influence on public health and shape the careers of future researchers. In addition to the grant, they provide technical, scientific, and mentoring support while you carry out your creative research project.

Almost 9 million people worldwide lose their lives to infectious diseases (IDs), which include tuberculosis (TB), malaria, and enteric infections. Sub-Saharan African (SSA) populations are disproportionately affected by these diseases, which are often preventable and treatable. If untreated, untreated infections lead to poor health outcomes and morbidity, higher mortality in coinfections with other infectious diseases, stigma-related mental disorders, and worsened social and health inequalities. The creation and execution of practical solutions to address the global health concerns of ID eradication depend heavily on research.

Award for GlaxoSmithKline Africa Open Lab 2024 Call for Proposals

  • Each prize may include up to 100,000 pounds, which might fund a project for up to 36 months.
  • The grant will provide money to pay for supplies, consumables, equipment, fieldwork and data collection fees, and research assistant costs associated with the approved research project.
  • Opportunities for training activities, such as short courses and training visits to pertinent research institutions, will be available to pursue in conjunction with GSK. These activities will be pertinent to accomplishing the project’s goals or developing a research career.
  • GSK will offer scientific support in addition to financial support for the term of the grant team. The application procedure will establish the degree of interaction, which will then be customized to meet the specific requirements of the project. To mentor successful applicants, GSK will look into establishing connections with experts from academic and research groups in Africa and throughout the world.
  • Tuition for degrees or fellowships is not funded.

Eligibility Criteria 

  • A basic biomedical scientist, a clinically qualified investigator, or a public health researcher who has not previously completed as principal investigator for a major research grant (100,000 pounds) and who is no more than five years from their highest postgraduate qualification (career breaks and time out of academic research will be taken into consideration) must be the principal investigator, and they must be African scientists in the early stages of their research and academic career.
  • A graduate degree is the minimum formal qualification needed. The majority of applicants should be anticipated to hold an MD, PhD, or MSc. Candidates may be employed as research staff members, have a junior fellowship, or be appointed as lecturers.
  • Must exhibit the qualifications needed to do the proposed job, as well as a history of success and continued dedication to health-related research. It is necessary to provide proof of research output, such as contributions to clinical guidelines or policy papers, presentations at scientific conferences, publications in peer-reviewed journals, and conference publications.
  • Working for an SSA-based academic or research organization. Applications from historically underrepresented universities and demographic groups are also encouraged.
  • A person who is based in an institution in Sub-Saharan Africa and is a national of that region.

Selection Criteria 

  • The following disease areas are the focus of this research proposal: enteric infections, malaria, tuberculosis, antimicrobial resistance (AMR) associated with these infectious diseases, and other emerging infectious diseases of particular relevance for Africa and neglected tropical diseases.
  • Research needs to focus on a few areas: the epidemiology of infectious diseases; the pathophysiology, etiology, prevention, and treatment of primary diseases; the substantial gaps in our understanding of the variety and causes of diseases; the ways in which diseases present and differ in clinical features; the ways in which diseases respond to medications and vaccines; the rise in antibiotic resistance associated with these infectious diseases; antibiotic stewardship; and strategies for enhancing access to and maximizing the use of medications and vaccines in Sub-Saharan Africa.
  • Will produce a substantial amount of data to support future funding requests, which may eventually result in grant money from other sources and/or research partnerships.
  • In order to affect changes in health policy and practice, proposals must outline the precise health needs their study will target as well as how they plan to interact with other stakeholders. Projects utilizing animal models or those centered on the development of drugs or vaccines will not be accepted.

Applications for the GlaxoSmithKline Africa Open Lab 2024 Call for Proposals

  • A two-stage review process will be applied to research grant applications. The only people invited to submit a complete application are those who make it past the concept stage. Funding recommendations will be made on the basis of scientific merit.
  • Visit the webpage for studies supported by GSK. To access the preliminary concept application form, you must first register.
  • Fill out the application for preliminary concepts and send it along with your resume (use the application form’s template).

Before submitting your application, carefully read the “Conditions for Applicants.”

Application Deadline

  • The deadline for receipt of applications is January 29, 2024.

Open this link for more details about the GlaxoSmithKline Africa Open Lab 2024.

LEAVE A REPLY

Please enter your comment!
Please enter your name here